Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessia Ligresti

Showing results (91-100 of 117) with videos related to

Pageof 12
Sort By:
Bioorganic & Medicinal Chemistry|July 15, 2009
Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profileRomano Silvestri, Alessia Ligresti, Giuseppe La Regina, et al.
British Journal of Pharmacology|November 15, 2005
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosisAlessia Ligresti, Maria Grazia Cascio, Gareth Pryce, et al.
European Journal of Medicinal Chemistry|February 13, 2014
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptorValentina Lucchesi, Teija Parkkari, Juha R Savinainen, et al.
Angewandte Chemie (International Ed. in English)|February 18, 2025
Profiling Allosteric Modulators of CB<sub>1</sub>R with an Allosteric FluoroprobeMiroslav Kosar, Themiya Perera, Rudolf L Z Ganzoni, et al.
Journal of Medicinal Chemistry|August 20, 2010
Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligandsSerena Pasquini, Alessia Ligresti, Claudia Mugnaini, et al.
Journal of Medicinal Chemistry|July 3, 2014
Discovery of glycine sulfonamides as dual inhibitors of sn-1-diacylglycerol lipase α and α/β-hydrolase domain 6Freek J Janssen, Hui Deng, Marc P Baggelaar, et al.
European Journal of Medicinal Chemistry|June 12, 2019
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatmentSerena Montanari, Ali Mokhtar Mahmoud, Letizia Pruccoli, et al.
European Journal of Pharmacology|July 23, 2013
PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell linesGiuseppina Gangemi, Patrizia Gazzerro, Donatella Fiore, et al.
Cells|September 28, 2021
Biosynthesis of the Novel Endogenous 15-Lipoxygenase Metabolites <i>N</i>-13-Hydroxy-octodecadienoyl-ethanolamine and 13-Hydroxy-octodecadienoyl-glycerol by Human Neutrophils and EosinophilsAnne-Sophie Archambault, Francesco Tinto, Élizabeth Dumais, et al.
Journal of Medicinal Chemistry|October 2, 2014
CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamidesValentina Lucchesi, Dow P Hurst, Derek M Shore, et al.
Pageof 12

Showing results (91-100 of 117) with videos related to

Sort By:
Pageof 12
Bioorganic & Medicinal Chemistry|July 15, 2009
Synthesis, cannabinoid receptor affinity, molecular modeling studies and in vivo pharmacological evaluation of new substituted 1-aryl-5-(1H-pyrrol-1-yl)-1H-pyrazole-3-carboxamides. 2. Effect of the 3-carboxamide substituent on the affinity and selectivity profileRomano Silvestri, Alessia Ligresti, Giuseppe La Regina, et al.
British Journal of Pharmacology|November 15, 2005
New potent and selective inhibitors of anandamide reuptake with antispastic activity in a mouse model of multiple sclerosisAlessia Ligresti, Maria Grazia Cascio, Gareth Pryce, et al.
European Journal of Medicinal Chemistry|February 13, 2014
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptorValentina Lucchesi, Teija Parkkari, Juha R Savinainen, et al.
Angewandte Chemie (International Ed. in English)|February 18, 2025
Profiling Allosteric Modulators of CB<sub>1</sub>R with an Allosteric FluoroprobeMiroslav Kosar, Themiya Perera, Rudolf L Z Ganzoni, et al.
Journal of Medicinal Chemistry|August 20, 2010
Investigations on the 4-quinolone-3-carboxylic acid motif. 3. Synthesis, structure-affinity relationships, and pharmacological characterization of 6-substituted 4-quinolone-3-carboxamides as highly selective cannabinoid-2 receptor ligandsSerena Pasquini, Alessia Ligresti, Claudia Mugnaini, et al.
Journal of Medicinal Chemistry|July 3, 2014
Discovery of glycine sulfonamides as dual inhibitors of sn-1-diacylglycerol lipase α and α/β-hydrolase domain 6Freek J Janssen, Hui Deng, Marc P Baggelaar, et al.
European Journal of Medicinal Chemistry|June 12, 2019
Discovery of novel benzofuran-based compounds with neuroprotective and immunomodulatory properties for Alzheimer's disease treatmentSerena Montanari, Ali Mokhtar Mahmoud, Letizia Pruccoli, et al.
European Journal of Pharmacology|July 23, 2013
PBOX-15 induces apoptosis and improves the efficacy of oxaliplatin in human colorectal cancer cell linesGiuseppina Gangemi, Patrizia Gazzerro, Donatella Fiore, et al.
Cells|September 28, 2021
Biosynthesis of the Novel Endogenous 15-Lipoxygenase Metabolites <i>N</i>-13-Hydroxy-octodecadienoyl-ethanolamine and 13-Hydroxy-octodecadienoyl-glycerol by Human Neutrophils and EosinophilsAnne-Sophie Archambault, Francesco Tinto, Élizabeth Dumais, et al.
Journal of Medicinal Chemistry|October 2, 2014
CB2-selective cannabinoid receptor ligands: synthesis, pharmacological evaluation, and molecular modeling investigation of 1,8-Naphthyridin-2(1H)-one-3-carboxamidesValentina Lucchesi, Dow P Hurst, Derek M Shore, et al.
Pageof 12